Quick Answer
Beam Therapeutics Inc. reported Net Income of -$79.99 million for fiscal year 2025.
Beam Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$79.99M | +78.8% |
| 2024 | -$376.74M | -184.3% |
| 2023 | -$132.53M | +54.2% |
| 2022 | -$289.09M | +22.0% |
| 2021 | -$370.64M | -90.5% |
| 2020 | -$194.59M | -148.4% |
| 2019 | -$78.33M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$112.73M | -16.6% | -10.2% |
| June 30, 2025 | -$102.29M | -12.3% | +6.4% |
| March 31, 2025 | -$109.27M | -10.7% | -13.0% |
| September 30, 2024 | -$96.67M | -0.6% | -6.2% |
| June 30, 2024 | -$91.05M | -10.0% | +7.7% |
| March 31, 2024 | -$98.67M | -2.3% | -2.7% |
| September 30, 2023 | -$96.09M | +12.3% | -16.1% |
| June 30, 2023 | -$82.78M | -15.0% | +14.2% |
- Beam Therapeutics Inc. showed an increase of +78.8% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Beam Therapeutics Inc.’s net income has declined by 2.1% (from -$78.33 million to -$79.99 million).
- The most recent figure is from Beam Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: